Corpus Intelligence IC Memo — PRESBYTERIAN HOSP FLOWER MOUND 2026-04-26 14:30 UTC
IC Memo — PRESBYTERIAN HOSP FLOWER MOUND
Investment Committee Memorandum | TX | 99 beds | Grade C | EBITDA uplift $15.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PRESBYTERIAN HOSP FLOWER MOUND

CCN 670068 | DENTON, TX | 99 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PRESBYTERIAN HOSP FLOWER MOUND is a 99-bed suburban community hospital in DENTON, TX with $215.0M in net patient revenue and a 28.3% operating margin. The hospital serves a payer mix of 26.1% Medicare, 5.6% Medicaid, and 68.2% commercial.

Thesis: Turnaround. Our ML models identify $15.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 28.3% to 35.6% (+736bps).

Net Revenue HCRIS$215.0M
Current EBITDA COMPUTED$60.8M
Operating Margin COMPUTED28.3%
Occupancy HCRIS54.6%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS34.7%
Distress Probability ML46.5%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
191
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 28.3% places it above the state median. Among 191 size-comparable peers (50-198 beds), the median margin is 2.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-198), prioritizing same-state peers. 191 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PRESBYTERIAN HOSP FLOWER MOUND (Target)TX99$215.0M28.3%
ROUND ROCK HOSPITALTX165$681.4M8.7%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
COVENANT CHILDRENS HOSPITALTX181$410.3M15.5%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
MEMORIAL HERMANN KATYTX196$381.4M13.3%
CHILDRENS HOSPITAL OF SAN ANTOTX174$376.5M-2.8%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.5M+210bp18mo
Cost to Collect4.5%2.5%$4.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.6M+122bp9mo
Clean Claim Rate88.0%96.0%$138K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.5M
Cost to Collect
$4.3M
Denial Rate Reduction
$4.3M
A/R Days Reduction
$2.6M
Clean Claim Rate
$138K
Total EBITDA Uplift$15.8M
Current EBITDA$60.8M
+ RCM Uplift+$15.8M
Pro Forma EBITDA$76.6M
Current Margin28.3%
Pro Forma Margin35.6%
WC Released (1x)$8.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$93.5M$559.2M5.98x43.0%
Base (11x exit)10.0x11.0x$93.5M$645.5M6.90x47.2%
Bull Case9.0x11.0x$84.2M$728.1M8.65x54.0%
Bull (12x exit)9.0x12.0x$84.2M$819.1M9.73x57.6%
Bear Case11.0x10.0x$102.9M$449.7M4.37x34.3%
Bear (11x exit)11.0x11.0x$102.9M$528.1M5.13x38.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 191 hospitals with 50-198 beds
  • Same-state prioritization (n=192)
  • Comp margins: P25=-9.5% / P50=2.7% / P75=12.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.